Clavis Pharma logo
  • Company
  • Technology
  • Products under development
  • Licensing and Partners
  • Investors
  • News & Events
    • 2010 Press releases
    • 2009 Press releases
    • 2008 Press releases
    • 2007 Press releases
    • 2006 Press releases
    • 2005 Press releases and earlier years
    • News
    • Subscribe
  • Contact us


Search

Subscribe to our newsletter


Terms/Glossary


News & Events > 2007 Press releases
Skriv ut

2007 Press releases


Displaying 1 - 10 of 11 articles


  • |«
  • « Previous
  • 1
  • 2
  • Next »
  • »|



19 December 2007
Clavis Pharma enters into Market Maker Agreement


15 October 2007
Clavis Pharma Completes its Executive Management Team


20 September 2007
Clavis Pharma Receives European Orphan Drug Designation of ELACYT for the Treatment of Acute Myeloid Leukaemia


17 September 2007
Clavis Pharma Strengthens Senior Management


24 August 2007
Second Quarter Report 2007


6 July 2007
Clavis Pharma announces initiation of malignant melanoma phase II clinical study


15 June 2007
Clavis Pharma presented preliminary clinical data on ELACYT at EHA


14 May 2007
Clavis Pharma appoints Chief Medical Officer


26 April 2007
First Quarter Report 2007


17 April 2007
Clavis Pharma presents preliminary clinical data on ELACYT™ at AACR


  • |«
  • « Previous
  • 1
  • 2
  • Next »
  • »|
Head Office: Parkveien 53 B, NO-0256 Oslo, Norway Tel: +47 24110950 Fax: +47 24110951 Disclaimer